Cost-Effectiveness of a Multicancer Early Detection Test in the US
The American Journal of Managed Care · 2024
DOI: 10.37765/ajmc.2024.89643 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Managed Care, 2024. Verfasst von Anuraag R Kansal und 6 weiteren Autor:innen. Beteiligte Einrichtung: GRAIL, Inc., 1525 O'Brien Dr, Menlo Park, CA 94025. Email: akansal@grailbio.com. Hauptthemen laut MEDLINE: Cost-Benefit Analysis, Early Detection of Cancer, Quality-Adjusted Life Years. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- GRAIL, Inc., 1525 O'Brien Dr, Menlo Park, CA 94025. Email: akansal@grailbio.com.
Zitieren
APA
Kansal, A. R., Tafazzoli, A., Shaul, A., Chavan, A., Ye, W., Zou, D., & Fendrick, A. M. (2024). Cost-Effectiveness of a Multicancer Early Detection Test in the US. The American Journal of Managed Care. https://doi.org/10.37765/ajmc.2024.89643
Vancouver
Kansal AR, Tafazzoli A, Shaul A, Chavan A, Ye W, Zou D, et al. Cost-Effectiveness of a Multicancer Early Detection Test in the US. The American Journal of Managed Care. 2024. doi:10.37765/ajmc.2024.89643
BibTeX
@article{Kansal2024,
author = {Kansal, Anuraag R and Tafazzoli, Ali and Shaul, Alissa and Chavan, Ameya and Ye, Weicheng and Zou, Denise and Fendrick, A Mark},
title = {Cost-Effectiveness of a Multicancer Early Detection Test in the US},
journal = {The American Journal of Managed Care},
year = {2024},
doi = {10.37765/ajmc.2024.89643}
}
EUVIMED